Viewing StudyNCT06481956



Ignite Creation Date: 2024-07-17 @ 10:49 AM
Last Modification Date: 2024-10-26 @ 3:33 PM
Study NCT ID: NCT06481956
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2024-07-01
First Post: 2024-06-25

Brief Title: T-DM1 Combined With CDK46 Inhibitor Ribociclib
Sponsor: Zheng Yabing
Organization: Zhejiang Cancer Hospital

Conditions & Keywords Data

Conditions:
Name
HER2-positive Advanced Breast Cancer
Keywords:
Name View
HER2-positive View
Advanced breast cancer View
Trastuzumab Emtansine View
Ribociclib View